Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2005
11/03/2005WO2005103705A2 Chemoselective fluorogenic molecular linkers and methods of their preparation and use
11/03/2005WO2005103704A1 Diagnostics and therapeutics for diseases associated with casein kinase 1, epsilon (csnk1e)
11/03/2005WO2005103703A2 Use of novel biomarkers for detection of testicular carcinoma in situ and derived cancers in human samples
11/03/2005WO2005103702A2 Diagnostics and therapeutics for diseases associated with cxc chemokine receptor 2 (cxcr2)
11/03/2005WO2005103701A1 Immunological assay method and reagent
11/03/2005WO2005103700A1 Ionic assay medium
11/03/2005WO2005103699A1 Masked solid supports
11/03/2005WO2005103698A2 Methods and antibodies for nitrofuran detection
11/03/2005WO2005103697A2 Immunoassays for buprenorphine and norbuprenorphine
11/03/2005WO2005103696A2 Systems and methods for versioning based triggers
11/03/2005WO2005103695A1 Gene detection method and gene detection apparatus
11/03/2005WO2005103694A2 Methods and fish models for identifying agents for treating bone and joint disease
11/03/2005WO2005103693A2 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
11/03/2005WO2005103692A2 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
11/03/2005WO2005103691A1 Device for sensing of motile living organisms and uses thereof
11/03/2005WO2005103690A2 Diagnostics and therapeutics for diseases associated with corticotropin releasing hormone receptor 2 (crhr2)
11/03/2005WO2005103689A1 Novel compounds for the treatment of alzheimer’s disease and methods for identifying same
11/03/2005WO2005103688A1 Device for analyzing the coagulation or aggregation behavior of blood
11/03/2005WO2005103687A2 System and method for providing optimal concentrations for medication infusions
11/03/2005WO2005103686A1 Method and appratus for predicting aggregation kinetics of a biologically active material
11/03/2005WO2005103685A1 Auxiliary tool for examination of biopsy specimen
11/03/2005WO2005103684A2 Diagnostics and therapeutics for diseases associated with cx3c chemokine receptor 1 (cx3cr1)
11/03/2005WO2005103683A1 Quantitative method of determining beryllium or a compound thereof in a sample
11/03/2005WO2005103682A1 Method for extracting intracellular complexes or compounds from a sample containing cells in a liquid suspension
11/03/2005WO2005103681A1 Diagnostics and therapeutics for diseases associated with endothelin receptor type b-like protein 1(etbr-lp-1)
11/03/2005WO2005103680A2 Method and device for increasing the selectivity of fet-based gas sensors
11/03/2005WO2005103677A1 Testing of breath
11/03/2005WO2005103673A1 A system and method for the determination of an electrical characteristic of a liquid
11/03/2005WO2005103670A1 Substrate for labo-on-a-chip
11/03/2005WO2005103669A1 Method for measuring blood components and biosensor and measuring instrument for use therein
11/03/2005WO2005103667A1 Fet-based gas sensor
11/03/2005WO2005103666A1 Fet-based gas sensor
11/03/2005WO2005103661A1 Method and apparatus for measuring the moisture content of a block of timber
11/03/2005WO2005103660A1 Method and device for determining the boiling point of a liquid medium
11/03/2005WO2005103655A1 Processable molecularly imprinted polymers
11/03/2005WO2005103654A2 Method for identification of compounds active in hiv virus replication
11/03/2005WO2005103653A1 Chemical sensors comprising fluorescent conjugated polymers as sensitive materials, and the use thereof for the detection or dosage of nitrated compounds
11/03/2005WO2005103652A1 Optoelectronic biochip
11/03/2005WO2005103300A2 Pattern recognition method for diagnosis of systemic autoimmune diseases
11/03/2005WO2005103295A2 Method and tools for analysis of nucleic acids
11/03/2005WO2005103291A1 Novel ligand of g-protein-conjugated receptor protein and use thereof
11/03/2005WO2005103290A1 Diagnostics and therapeutics for diseases associated with aspartyl aminopeptidase (dnpep)
11/03/2005WO2005103286A1 Method of measuring activity of homocysteine thiolactone hydrolase
11/03/2005WO2005103285A2 Systems and methods for indicating oxidation of consumer products
11/03/2005WO2005103283A1 Novel method of screening
11/03/2005WO2005103282A1 Method of measuring active oxygen
11/03/2005WO2005103281A2 Platelet biomarkers for the detection of disease
11/03/2005WO2005103263A1 Bone delivery conjugates and method of using same to target proteins to bone
11/03/2005WO2005103259A1 Sars-cov nucleocapsid protein epitopes and uses thereof
11/03/2005WO2005103257A1 GENE ENCODING GUANINE NUCLEOTIDE EXCHANGE FACTOR BINDING TO RhoA
11/03/2005WO2005103256A1 Gene encoding gtpase activating protein and gene product thereof
11/03/2005WO2005103255A1 Formylpeptide receptor (fpr) as a target for anti-malignant glioma therapy
11/03/2005WO2005103249A1 Probe and primer for tubercle bacillus detection, and method of detecting human tubercle bacillus therewith
11/03/2005WO2005103240A1 Diagnostics and therapeutics for diseases associated with casein kinase 1, delta, isoform 1 (csnk1d iso 1)
11/03/2005WO2005103232A2 Isolation and culture of a high purity population of cone photoreceptor cells by tissue dissociation and pna-panning, and biological applications thereof
11/03/2005WO2005103214A2 Perfume compositions
11/03/2005WO2005103162A1 Fluorescent labeled nucleotide derivatives
11/03/2005WO2005103069A1 Multidimensional protein separation
11/03/2005WO2005103064A1 Novel sugar chain-supported carbosilane dendrimer
11/03/2005WO2005102939A1 A device and method for measuring glycosaminoglycans in body fluids
11/03/2005WO2005102938A2 Antibodies specific for bcr-abl fusion protein and uses thereof
11/03/2005WO2005102456A1 Composition and method for cancer treatment
11/03/2005WO2005102396A2 Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof
11/03/2005WO2005102395A1 Novel use of aim3 acting as a tumor suppressor
11/03/2005WO2005102311A1 Agonists of a bitter taste receptor and uses thereof
11/03/2005WO2005102176A1 Xanthene dyes
11/03/2005WO2005102155A1 Infusion devices, glucose meters and/or monitors with smell sniffing technology
11/03/2005WO2005102154A2 Blood glucose meter having integral lancet device and test strip storage vial for single handed use and methods for using same
11/03/2005WO2005102040A1 Tlr ligand and il-1 response-injured animal model
11/03/2005WO2005102019A2 Treatment of fluids and/or sludge with electro plasma
11/03/2005WO2005101956A2 Method of identifying therapeutic compounds which can be used for the treatment and/or prevention of infections and diseases caused by human herpesviruses
11/03/2005WO2005088306A3 Biologically-active dna-binding sites and related methods
11/03/2005WO2005085873A3 Detection of preterm labour
11/03/2005WO2005085869A3 Determination of analyte characteristics based upon binding properties
11/03/2005WO2005085472A3 Diagnostic and therapeutic use of mal2 gene and protein for neurodegenerative diseases
11/03/2005WO2005080967A8 Method and device for the characterization of interactions between different species
11/03/2005WO2005079822A3 Pharmaceutical composition comprising a fibrin matrix and dermal fibroblasts for the treatment of wounds
11/03/2005WO2005075662A3 Diagnostics and therapeutics for diseases associated with kallikrein 2 (klk2)
11/03/2005WO2005069737A3 Method and system for detecting analytes
11/03/2005WO2005066363A3 Cancer specific gene ccndbp1
11/03/2005WO2005066211A3 Fibroblast growth factor receptors 1, 2, 3, and 4 as targets for therapeutic intervention
11/03/2005WO2005060713A3 Method of inhibiting candida-related infections using donor selected or donor stimulated immunoglobulin compositions
11/03/2005WO2005059561A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 31 (gpr31)
11/03/2005WO2005059560A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor mc2 (mc2)
11/03/2005WO2005059547A3 Assay
11/03/2005WO2005055936A3 Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells
11/03/2005WO2005053835A3 Artificial receptors including gradients
11/03/2005WO2005051295A3 Asymmetrically branched polymer conjugates and microarray assays
11/03/2005WO2005050218A3 Diagnostic, prognostic and therapeutic method used for the analysis and treatment of malign tumours
11/03/2005WO2005050202A3 Biological materials and uses thereof
11/03/2005WO2005050197A3 Diagnostics and therapeutics for diseases associated with protein-coupled inwardly rectifying potassium channel girk4 (girk4)
11/03/2005WO2005038000A3 T cell epitopes useful in mycobacterium tuberculosis vaccine and as diagnostic tools and methods for identifying same
11/03/2005WO2005028620A3 Histone modifications as binary switches controlling gene expression
11/03/2005WO2005026735A3 Differentially expressed tumour-specific polypeptides for use in the diagnosis and treatment of cancer
11/03/2005WO2005024695A3 Methods for encoding non-biological information on microarrays
11/03/2005WO2005024385A3 Sample processing system
11/03/2005WO2005019831B1 Methods for reducing complexity of a sample using small epitope antibodies
11/03/2005WO2005010485A3 Methods for detecting and analyzing n-glycolylneuraminic acid (neu5gc) in biological materials
11/03/2005WO2005009952A3 Photoluminescent heterodiamondoids as biological labels
11/03/2005WO2005002518A3 Methods for treating and preventing cardiac arrhythmia
1 ... 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 ... 3937